
Apyx Medical (APYX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Apyx Medical (APYX) last issued guidance on August 6, 2026 for fiscal year 2026. The company guided revenue in the range of $59M - $60M for the period.
Compared to prior guidance, Apyx Medical maintained its revenue forecast from a prior range of $59M - $60M.
Apyx Medical has issued 25 guidance updates between November 10, 2022 and August 6, 2026. During this period, the company raised its outlook 8 times and lowered it 9 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.09 | $-0.11 | $-0.06 | $-0.10 |
| Actual | $-0.07 | $-0.05 | $-0.03 | $-0.05 |
| Surprise | +22.2% | +54.5% | +50.0% | +50.0% |
| Revenue | ||||
| Estimate | $13.3M | $11.0M | $19.1M | $12.0M |
| Actual | $13.9M | $12.5M | $19.2M | $12.9M |
| Surprise | +4.19% | +13.9% | +0.17% | +7.30% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.09 | $-0.06 | $-0.07 | $-0.07 |
| Revenue | ||||
| Consensus | $13.4M | $19.7M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.07 | $-0.09 | 22.2 % |
| Q1 | May 7, 2026 | $-0.05 | $-0.11 | 54.5 % |
| Q4 | Mar 10, 2026 | $-0.03 | $-0.06 | 50.0 % |
| Q3 | Nov 6, 2025 | $-0.05 | $-0.10 | 50.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $13.88M | $13.33M | 4.19 % |
| Q1 | May 7, 2026 | $12.49M | $10.97M | 13.9 % |
| Q4 | Mar 10, 2026 | $19.16M | $19.13M | 0.17 % |
| Q3 | Nov 6, 2025 | $12.88M | $12.00M | 7.30 % |